Loading
VP
Valeant Pharmaceuticals International, Inc. Stock: price and insider trades · Canada
Valeant Pharmaceuticals International, Inc.: what insiders have been doing
Valeant Pharmaceuticals International, Inc. is a listed company. Filings by its managers are published through SEDI. No insider at Valeant Pharmaceuticals International, Inc. has published a filing in the past twelve months. The most recent one dates from 28 May 2018.
Our records for Valeant Pharmaceuticals International, Inc. go back to 2015, with 11 purchases and 2 sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
75
Thresholds
n/a
Buy Volume
€5M
11 ops. · all time
Sell Volume
€37M
2 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 28 May 2018
Declarations75 total
21,612 sharesCommon SharesTSXSEDI:3188534
15,000 shares@ CA$21.8321.5% of flowCommon SharesTSXSEDI:3184878
Canonical exit: 13 Aug 2018 (T+90)
186,684 shares@ CA$18.3131.5% of flowCommon SharesTSXSEDI:3181672
91,942 shares@ CA$18.3115.5% of flowCommon SharesTSXSEDI:3181677
25,406 shares@ CA$18.0729.8% of flowCommon SharesTSXSEDI:3181600
3,522 shares@ CA$18.074.1% of flowCommon SharesTSXSEDI:3181604
21,612 shares@ CA$18.0775.4% of flowCommon SharesTSXSEDI:3178893
15,000 shares@ CA$16.09845.9% of flowCommon SharesTSXSEDI:3152739
Canonical exit: 11 Jun 2018 (T+90)
30,000 shares@ CA$16.054.3% of flowCommon SharesTSXSEDI:3152738
Canonical exit: 11 Jun 2018 (T+90)
10,000 shares@ CA$15.349.6% of flowCommon SharesTSXSEDI:3152737
Canonical exit: 6 Jun 2018 (T+90)
1,826 shares@ CA$23.859.9% of flowCommon SharesTSXSEDI:3116457
3,649 shares@ CA$23.8530.8% of flowCommon SharesTSXSEDI:3116440
1,557 shares@ CA$23.8513.0% of flowCommon SharesTSXSEDI:3116443
4,095 shares@ CA$23.8534.2% of flowCommon SharesTSXSEDI:3116442
4,266 shares@ CA$23.8523.1% of flowCommon SharesTSXSEDI:3116454
8,191 shares@ CA$23.8569.2% of flowCommon SharesTSXSEDI:3116436
Common SharesTSXSEDI:3026332
Common SharesTSXSEDI:3026335
Common SharesTSXSEDI:3026336
Common SharesTSXSEDI:3026334
Common SharesTSXSEDI:3026337
Common SharesTSXSEDI:3026333
Common SharesTSXSEDI:3026340
Common SharesTSXSEDI:3026339
Common SharesTSXSEDI:3026312
25 of 75 declarations
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceutical and healthcare products. It is listed on the Toronto Stock Exchange under the symbol XTSE.
